Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026
Same author

Diabetic retinopathy screening in Australian general practice: persistently low uptake despite national guidelines and equity initiatives.

Journal of diabetes and metabolic disorders·2025
Same author

Inherited retinal disease in global Indigenous populations: A scoping review.

Survey of ophthalmology·2025
Same author

Effective refractive error coverage in adults: a systematic review and meta-analysis of updated estimates from population-based surveys in 76 countries modelling the path towards the 2030 global target.

The Lancet. Global health·2025
Same author

National Eye Institute's (NEI) coordination efforts and current opportunities for sustainability, adaptation, and climate resilience in global eye health - ARVO 2023 session commentary.

Eye (London, England)·2023
Same author

A foodborne outbreak of campylobacteriosis at a wedding - Melbourne, Australia, 2022.

Communicable diseases intelligence (2018)·2023

Related Experiment Video

Updated: Jun 6, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Glaucoma prevalence in Indigenous Australians.

Brian E Chua1, Jing Xie, Anna-Lena Arnold

  • 1Melbourne School of Population Health, University of Melbourne, Carlton, Victoria 3053, Australia. h.taylor@unimelb.edu.au

The British Journal of Ophthalmology
|November 30, 2010
PubMed
Summary
This summary is machine-generated.

Glaucoma affects 2.2% of Indigenous Australians aged 40 and over. While not a common cause of vision loss, this study identified definable rates of the disease in the population.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
07:00

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

Related Experiment Videos

Last Updated: Jun 6, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
07:00

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

Area of Science:

  • Ophthalmology
  • Public Health
  • Indigenous Health

Background:

  • Glaucoma is a leading cause of irreversible blindness globally.
  • Understanding the prevalence of glaucoma in Indigenous Australian populations is crucial for targeted health interventions.
  • Previous estimates of glaucoma prevalence in this demographic are limited.

Purpose of the Study:

  • To determine the prevalence of glaucoma among Aboriginal and Torres Strait Islander adults aged 40 years and older.
  • To identify risk factors associated with glaucoma in this population.
  • To assess the contribution of glaucoma to vision impairment and blindness.

Main Methods:

  • A population-based survey was conducted across 30 randomly selected communities in Australia.
  • Participants aged 40 years and above from Aboriginal and Torres Strait Islander communities were recruited.
  • Glaucoma was diagnosed based on specific cup-to-disc ratio (CDR) and Frequency Doubling Test criteria.

Main Results:

  • A total of 1189 eligible participants were examined, with a 72% response rate.
  • The overall prevalence of glaucoma was found to be 2.2% (95% CI 1.6% to 3.6%).
  • Older age, male gender, lower education levels, and a history of glaucoma were associated with increased odds in univariate analysis, but only a history of glaucoma remained significant in multivariate analysis.

Conclusions:

  • Glaucoma is present in the Indigenous Australian population, though it is an infrequent cause of vision loss.
  • The findings suggest potential genetic influences or differences in diagnostic criteria compared to previous studies.
  • Further research is warranted to explore the specific drivers and management of glaucoma in this population.